Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

Yoshinaga Saeki, Cornel Fraefel, Tomotsugu Ichikawa, Xandra O. Breakefield, E. Antonio Chiocca

Research output: Contribution to journalArticle

178 Citations (Scopus)

Abstract

Herpes simplex virus type 1 (HSV-1) amplicons are prokaryotic plasmids containing one or more transcriptional units and two cis-acting HSV-1 sequences: a viral origin of DNA replication and a viral DNA cleavage/packaging signal. In the presence of HSV-1 "helper" functions, amplicons are replicated and packaged into HSV-1 virions. Despite recent improvements in packaging methods, stocks of amplicon vectors are still contaminated with replication-competent helper virus at a frequency of 10-4-10-6. To overcome this problem, we report that: (i) genetic modifications of HSV-1 genomes can be routinely achieved in Escherichia coli, either by homologous or site-specific recombination, (ii) a novel HSV-1 bacterial artificial chromosome (fHSVΔpacΔ27 0+), which has a deletion in the essential gene encoding ICP27 and an addition of ICP0 "stuffer" sequences to increase its size to 178 kb, supports the replication and packaging of cotransfected amplicon DNA without generating replication-competent helper virus (<1 helper virus per 108 TU amplicon vectors), and (iii) the resulting amplicon stocks have titers of up to 3-10 × 108 TU/ml after concentration. Elimination of replication-competent helper virus from HSV-1 amplicon vector stocks further improves safety in gene transfer applications.

Original languageEnglish
Pages (from-to)591-601
Number of pages11
JournalMolecular Therapy
Volume3
Issue number4
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Helper Viruses
Bacterial Artificial Chromosomes
Virus Assembly
Human Herpesvirus 1
DNA
Viral DNA
Product Packaging
DNA Packaging
DNA Cleavage
Replication Origin
Essential Genes
DNA Replication
Virion
Genetic Recombination
Plasmids
Genome
Escherichia coli
Safety

Keywords

  • Amplicon
  • BAC
  • Cre/loxP
  • Gene therapy
  • Helper virus-free
  • Herpes virus
  • Homologous recombination
  • RecA
  • Site-specific recombination

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. / Saeki, Yoshinaga; Fraefel, Cornel; Ichikawa, Tomotsugu; Breakefield, Xandra O.; Chiocca, E. Antonio.

In: Molecular Therapy, Vol. 3, No. 4, 2001, p. 591-601.

Research output: Contribution to journalArticle

Saeki, Yoshinaga ; Fraefel, Cornel ; Ichikawa, Tomotsugu ; Breakefield, Xandra O. ; Chiocca, E. Antonio. / Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. In: Molecular Therapy. 2001 ; Vol. 3, No. 4. pp. 591-601.
@article{e4b2275116f84f0b8066054306ddfb39,
title = "Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome",
abstract = "Herpes simplex virus type 1 (HSV-1) amplicons are prokaryotic plasmids containing one or more transcriptional units and two cis-acting HSV-1 sequences: a viral origin of DNA replication and a viral DNA cleavage/packaging signal. In the presence of HSV-1 {"}helper{"} functions, amplicons are replicated and packaged into HSV-1 virions. Despite recent improvements in packaging methods, stocks of amplicon vectors are still contaminated with replication-competent helper virus at a frequency of 10-4-10-6. To overcome this problem, we report that: (i) genetic modifications of HSV-1 genomes can be routinely achieved in Escherichia coli, either by homologous or site-specific recombination, (ii) a novel HSV-1 bacterial artificial chromosome (fHSVΔpacΔ27 0+), which has a deletion in the essential gene encoding ICP27 and an addition of ICP0 {"}stuffer{"} sequences to increase its size to 178 kb, supports the replication and packaging of cotransfected amplicon DNA without generating replication-competent helper virus (<1 helper virus per 108 TU amplicon vectors), and (iii) the resulting amplicon stocks have titers of up to 3-10 × 108 TU/ml after concentration. Elimination of replication-competent helper virus from HSV-1 amplicon vector stocks further improves safety in gene transfer applications.",
keywords = "Amplicon, BAC, Cre/loxP, Gene therapy, Helper virus-free, Herpes virus, Homologous recombination, RecA, Site-specific recombination",
author = "Yoshinaga Saeki and Cornel Fraefel and Tomotsugu Ichikawa and Breakefield, {Xandra O.} and Chiocca, {E. Antonio}",
year = "2001",
doi = "10.1006/mthe.2001.0294",
language = "English",
volume = "3",
pages = "591--601",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

AU - Saeki, Yoshinaga

AU - Fraefel, Cornel

AU - Ichikawa, Tomotsugu

AU - Breakefield, Xandra O.

AU - Chiocca, E. Antonio

PY - 2001

Y1 - 2001

N2 - Herpes simplex virus type 1 (HSV-1) amplicons are prokaryotic plasmids containing one or more transcriptional units and two cis-acting HSV-1 sequences: a viral origin of DNA replication and a viral DNA cleavage/packaging signal. In the presence of HSV-1 "helper" functions, amplicons are replicated and packaged into HSV-1 virions. Despite recent improvements in packaging methods, stocks of amplicon vectors are still contaminated with replication-competent helper virus at a frequency of 10-4-10-6. To overcome this problem, we report that: (i) genetic modifications of HSV-1 genomes can be routinely achieved in Escherichia coli, either by homologous or site-specific recombination, (ii) a novel HSV-1 bacterial artificial chromosome (fHSVΔpacΔ27 0+), which has a deletion in the essential gene encoding ICP27 and an addition of ICP0 "stuffer" sequences to increase its size to 178 kb, supports the replication and packaging of cotransfected amplicon DNA without generating replication-competent helper virus (<1 helper virus per 108 TU amplicon vectors), and (iii) the resulting amplicon stocks have titers of up to 3-10 × 108 TU/ml after concentration. Elimination of replication-competent helper virus from HSV-1 amplicon vector stocks further improves safety in gene transfer applications.

AB - Herpes simplex virus type 1 (HSV-1) amplicons are prokaryotic plasmids containing one or more transcriptional units and two cis-acting HSV-1 sequences: a viral origin of DNA replication and a viral DNA cleavage/packaging signal. In the presence of HSV-1 "helper" functions, amplicons are replicated and packaged into HSV-1 virions. Despite recent improvements in packaging methods, stocks of amplicon vectors are still contaminated with replication-competent helper virus at a frequency of 10-4-10-6. To overcome this problem, we report that: (i) genetic modifications of HSV-1 genomes can be routinely achieved in Escherichia coli, either by homologous or site-specific recombination, (ii) a novel HSV-1 bacterial artificial chromosome (fHSVΔpacΔ27 0+), which has a deletion in the essential gene encoding ICP27 and an addition of ICP0 "stuffer" sequences to increase its size to 178 kb, supports the replication and packaging of cotransfected amplicon DNA without generating replication-competent helper virus (<1 helper virus per 108 TU amplicon vectors), and (iii) the resulting amplicon stocks have titers of up to 3-10 × 108 TU/ml after concentration. Elimination of replication-competent helper virus from HSV-1 amplicon vector stocks further improves safety in gene transfer applications.

KW - Amplicon

KW - BAC

KW - Cre/loxP

KW - Gene therapy

KW - Helper virus-free

KW - Herpes virus

KW - Homologous recombination

KW - RecA

KW - Site-specific recombination

UR - http://www.scopus.com/inward/record.url?scp=0034991897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034991897&partnerID=8YFLogxK

U2 - 10.1006/mthe.2001.0294

DO - 10.1006/mthe.2001.0294

M3 - Article

C2 - 11319922

AN - SCOPUS:0034991897

VL - 3

SP - 591

EP - 601

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 4

ER -